These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 25829808)
21. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients. Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875 [TBL] [Abstract][Full Text] [Related]
22. N-terminal pro-brain natriuretic peptide--a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women. Mouly-Bertin C; Bissery A; Milon H; Dzudie A; Rabilloud M; Bricca G; Vincent M; Lantelme P Arch Cardiovasc Dis; 2008 May; 101(5):307-15. PubMed ID: 18656089 [TBL] [Abstract][Full Text] [Related]
23. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care. Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282 [TBL] [Abstract][Full Text] [Related]
24. Natriuretic peptides in patients with aortic stenosis. Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366 [TBL] [Abstract][Full Text] [Related]
25. The Electrocardiogram Is a Poor Diagnostic Tool to Detect Left Ventricular Hypertrophy in Children: A Comparison with Echocardiographic Assessment of Left Ventricular Mass. Bratincsák A; Williams M; Kimata C; Perry JC Congenit Heart Dis; 2015; 10(4):E164-71. PubMed ID: 25600360 [TBL] [Abstract][Full Text] [Related]
26. N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy. Garcia S; Akbar MS; Ali SS; Kamdar F; Tsai MY; Duprez DA Int J Cardiol; 2010 Sep; 143(3):349-52. PubMed ID: 19356808 [TBL] [Abstract][Full Text] [Related]
27. Electrocardiographic left ventricular hypertrophy has low diagnostic accuracy in middle-aged subjects. Vottonen P; Husso M; Sipola P; Vanninen R; Peuhkurinen K; Magga J Blood Press; 2007; 16(5):328-34. PubMed ID: 17852087 [TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram. Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375 [TBL] [Abstract][Full Text] [Related]
30. Revision of the Sokolow-Lyon-Rappaport and cornell voltage criteria for left ventricular hypertrophy. Rodrigues SL; D'Angelo L; Pereira AC; Krieger JE; Mill JG Arq Bras Cardiol; 2008 Jan; 90(1):46-53. PubMed ID: 18317640 [TBL] [Abstract][Full Text] [Related]
31. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease. Cordeiro AC; Lindholm B; Sousa MG; Picotti JC; Nunes GJ; Santana MR; Grimaldi W; Amparo FC; Amodeo C; Carrero JJ J Hypertens; 2014 Feb; 32(2):439-45. PubMed ID: 24317549 [TBL] [Abstract][Full Text] [Related]
32. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy. Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855 [TBL] [Abstract][Full Text] [Related]
33. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869 [TBL] [Abstract][Full Text] [Related]
34. Performance of classic electrocardiographic criteria for left ventricular hypertrophy in an African population. Jaggy C; Perret F; Bovet P; van Melle G; Zerkiebel N; Madeleine G; Kappenberger L; Paccaud F Hypertension; 2000 Jul; 36(1):54-61. PubMed ID: 10904012 [TBL] [Abstract][Full Text] [Related]
35. Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy. Okin PM; Roman MJ; Devereux RB; Pickering TG; Borer JS; Kligfield P Hypertension; 1998 Apr; 31(4):937-42. PubMed ID: 9535418 [TBL] [Abstract][Full Text] [Related]
36. Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram. Limkakeng AT; Drake W; Mani G; Freeman D; Best R; Newby LK; Chandra A Am J Emerg Med; 2012 Jan; 30(1):214-7. PubMed ID: 21185671 [TBL] [Abstract][Full Text] [Related]
37. Comparison of usefulness of Sokolow and Cornell criteria for left ventricular hypertrophy in subjects aged <20 years versus >30 years. Grossman A; Prokupetz A; Koren-Morag N; Grossman E; Shamiss A Am J Cardiol; 2012 Aug; 110(3):440-4. PubMed ID: 22534054 [TBL] [Abstract][Full Text] [Related]
38. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population. Cuspidi C; Facchetti R; Bombelli M; Sala C; Grassi G; Mancia G J Hypertens; 2014 Apr; 32(4):921-8. PubMed ID: 24406778 [TBL] [Abstract][Full Text] [Related]
39. [Value of the electrocardiographic Cornell criteria for detecting left ventricular hypertrophy in elderly men]. Zeng XZ; Liu DP; He Q; Guo HL; Fang F; Liu DG; Dong R; Zeng HY Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):56-8. PubMed ID: 19671355 [TBL] [Abstract][Full Text] [Related]
40. Limitations of Electrocardiography for Detecting Left Ventricular Hypertrophy or Concentric Remodeling in Athletes. Hedman K; Moneghetti KJ; Hsu D; Christle JW; Patti A; Ashley E; Hadley D; Haddad F; Froelicher V Am J Med; 2020 Jan; 133(1):123-132.e8. PubMed ID: 31738876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]